EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
    1.2.1.88 | Neoplasms |
22206977 |
Aldehyde dehydrogenases and cell proliferation. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
1
1
0 |
| 1.2.1.88 | Atherosclerosis |
33268892 |
ALDH4A1 is an atherosclerosis auto-antigen targeted by protective antibodies. |
causal interaction
therapeutic application
unassigned |
4
2
0 |
| 1.2.1.88 | l-glutamate gamma-semialdehyde dehydrogenase deficiency |
16934832 |
Crystal Structure of Thermus thermophilus Delta(1)-Pyrroline-5-carboxylate Dehydrogenase. |
causal interaction
unassigned |
1
0 |
| 1.2.1.88 | Metabolic Syndrome |
26692068 |
In Vivo Exposures to Particulate Matter Collected from Saudi Arabia or Nickel Chloride Display Similar Dysregulation of Metabolic Syndrome Genes. |
causal interaction
unassigned |
2
0 |
| 1.2.1.88 | Cataract |
18843385 |
Investigation of eight candidate genes on chromosome 1p36 for autosomal dominant total congenital cataract. |
unassigned |
0 |
| 1.2.1.88 | Epilepsy |
34037900 |
Metabolic epilepsy in hyperprolinemia type II due to a novel nonsense ALDH4A1 gene variant. |
causal interaction
ongoing research
unassigned |
1
2
0 |
| 1.2.1.88 | Infections |
26284090 |
P5CDH affects the pathways contributing to Pro synthesis after ProDH activation by biotic and abiotic stress conditions. |
causal interaction
ongoing research
unassigned |
1
1
0 |
| 1.2.1.88 | Metabolic Diseases |
10971205 |
Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease. |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 1.2.1.88 | Fascioliasis |
4402 |
Proline in fascioliasis: III. Activities of pyrroline-5-carboxylic acid reductase and pyrroline-5-carboxylic acid dehydrogenase in Fasciola. |
unassigned |
0 |
| 1.2.1.88 | Granuloma |
6895205 |
Proline trapping in granulomas, the site of collagen biosynthesis in murine schistosomiasis. |
diagnostic usage
ongoing research
unassigned |
4
2
0 |
